North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on June 2, 2026

MAIA Biotechnology Announces Open Market Purchases by CEO and Director
USOSM Supports OMS Foundation Through 2026 Matching-Gift Incentive
Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at Elbit
Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL)
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
Myriad Genetics Names Raj Jampa as New Chief Technology Officer
Premier Health of America Announces Anticipated Delay in Filing Interim Financial Statements and Application for Management Cease Trade Order
Montara Therapeutics Receives Research Grant from The Michael J. Fox Foundation to Advance Parkinson’s Disease Program
Evosep and Molecular You Announce Strategic Collaboration to Scale Standardized Multi-Omic Testing Globally
Philips receives FDA 510(k) clearance for Elevate Plus for EPIQ Elite and Affiniti, delivering AI advancements in general imaging ultrasound
Signati™ Medical Receives FDA IDE Approval for Pivotal Study of the Separo™ Vessel Sealing System
Oncolytics Biotech® Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website
UNDEFEATED UFC CHAMPION ILIA TOPURIA PARTNERS WITH NEUROTECHNOLOGY INNOVATOR VIELIGHT AHEAD OF UFC FREEDOM 250 MAIN EVENT
Scene Health Releases New Guide on Medication Adherence Support for Leaders Advancing Rural Health Transformation
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML
Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris   
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Share this page:

Sign up for:

North Carolina Wellness News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.